Jillian McKee, M.D., Ph.D., a Pediatric Epilepsy Fellow at the Children's Hospital of Philadelphia, will deliver this presentation on data-driven approaches to reconstructing disease trajectories in SYNGAP1-related disorders.

At this year’s Individualizing Medicine Conference, attendees will receive an inside look into how Mayo Clinic is connecting and accessing biospecimens from study design to clinical integration.

This Sepsis Alliance Symposium, focused on precision medicine in sepsis care and examining host-directed diagnosis and treatment for infectious diseases and sepsis, will allow learners to better understand the host response and how precision medicine might be applied.

The American Cancer Society Cancer Action Network is hosting a half-day conference exploring the challenges of equitable pharmacogenomics research and testing for cancer patients.

Alexion/AstraZeneca Rare Disease, the EveryLife Foundation for Rare Diseases, the National Society of Genetic Counselors, and the Personalized Medicine Coalition will convene a reception with Congressional leaders and rare disease experts on Tuesday, July 18, at 5:30 p.m. to discuss how Congress, patient advocates, and industry leaders can work together to deliver faster diagnoses for rare disease patients. The reception will take place in Room 2322 of the Rayburn building. RSVP to Gwen Fuller at gfuller@forbes-tate.com.

The Next Generation Dx Summit convenes key opinion leaders across the world to share recent progress in diagnostic advancement and technology innovation.

The Rally for Medical Research brings advocates from around the country to Washington, DC, to call on policymakers to make funding for the National Institutes of Health a national priority and to raise awareness about the importance of investments in biomedical research.